A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis
Han Zou(University of Pittsburgh), Baoli Hu(Shenyang University of Technology), Michelle Ly(Hospital for Sick Children), Evridiki Asimakidou(University of Cambridge), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center), Vladislav Razskazovskiy(University of Pittsburgh), Karl Herrup(University of Pittsburgh), Jieqi Qian(Children's Hospital of Pittsburgh), Jeremy N. Rich(Duke University), Gary Kohanbash(University of Pittsburgh), Alberto Broniscer(St Nicholas Hospital), Tadanori Tomita(Northwestern University), Guifa Xi(Northwestern University), Olivier Saulnier(Hospital for Sick Children), George K. Gittes(University of Pittsburgh), Bradley Poore(University of Pittsburgh), Eric H. Raabe(Johns Hopkins University), Dandan Sun(Institute for Neurodegenerative Disorders), Apeng Chen(University of Pittsburgh), Sameer Agnihotri(University of Pittsburgh), Stephen C. Mack(St. Jude Children's Research Hospital), Deanna Ayrapetian(University of Pittsburgh), Siyi Wanggou(Central South University), Beth Stronach(University of Pittsburgh), Ian F. Pollack(University of Pittsburgh), Adam Resnick(Children's Hospital of Philadelphia), Robert M. Friedlander(University of Pittsburgh), Yongchang Guan(University of Pittsburgh), Michael D. Taylor(Hospital for Sick Children), Zhengwei Li(Facing Our Risk of Cancer Empowered), Xuejun Li(Peking University), Vaibhav Sharma(University of Pittsburgh), Zhongliang Hu(Central South University), Emily Brown(University of Pittsburgh), Shunjin Xia(Central South University), Bin Xie(Central South University), Wendy Fellows-Mayle(University of Pittsburgh), Sarah J. Hainer(University of Pittsburgh), Fei Liu(Shandong Academy of Pharmaceutical Sciences), Songjian Lu(St. Jude Children's Research Hospital)
Cited by 34
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867